In a world first, a new study conducted by a California-based neurotechnology company has recorded two-way communication between sleeping individuals during lucid dreaming. Using special tracking ...
Neumora Therapeutics, Inc. (NMRA) is gearing up to report results from one of its phase 3 studies, which is using its drug Navacaprant for the treatment of patients with major depressive disorder (MDD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback